Skip to main content Accessibility help
×
Home

Vagus Nerve Stimulation for Epilepsy: The Notre-Dame Hospital Experience

  • Mehdi Qiabi (a1), Alain Bouthillier (a2), Lionel Carmant (a1) and Dang Khoa Nguyen (a1)

Abstract

Purpose:

Retrospective study assessing the efficacy and tolerability of vagus nerve stimulation (VNS) for the treatment of refractory epilepsy at Notre-Dame Hospital.

Methodology:

Chart review of all adult epileptic patients treated by VNS with ≥ 1 year follow-up. Responders were defined as patients with ≥ 50% reduction of baseline seizure frequency.

Results:

Thirty-four patients (14M; mean age = 29.9 yrs) received a VNS. Sub-pectoralis implantation (n = 25) was more frequent than subcutaneous (n = 9). Most patients suffered from intractable partial epilepsy. After 6 months, 12 months, 24 months, and 36 months, 14/34 patients (41%), 16/34 patients (47%), 17/30 patients (57%) and 12/20 patients (60%) respectively were responders. Two patients (6%) became seizure-free. Complications related to implantation were minor: eight cases of limited cervical hypoesthesia, two minor scar infections and one Horner syndrome. Adverse events (voice hoarseness, throat paresthesia, coughing) related to stimulation were generally mild and tended to wane over time. However, a reduction in seizure frequency did not translate into a reduction in medication, as only 9% of responders had less antiepileptic medication at last follow-up compared to baseline.

Conclusion:

VNS as practiced at Notre-Dame hospital is an efficacious and safe treatment for refractory epilepsy. Quotas allotted to epilepsy centers in the province of Quebec should be lifted or increased to allow more patients to benefit from this therapeutic device.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Vagus Nerve Stimulation for Epilepsy: The Notre-Dame Hospital Experience
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Vagus Nerve Stimulation for Epilepsy: The Notre-Dame Hospital Experience
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Vagus Nerve Stimulation for Epilepsy: The Notre-Dame Hospital Experience
      Available formats
      ×

Copyright

Corresponding author

Neurology Service, Notre-Dame Hospital, 1560 rue Sherbrooke Est, Montréal, Québec, H2L 4M1, Canada

References

Hide All
1.Tellez-Zenteno, JF, Pondal-Sordo, M, Matijevic, S, Wiebe, S.National and regional prevalence of self-reported epilepsy in Canada. Epilepsia. 2004;45(12):16239.
2.Kwan, P, Brodie, MJ.Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):3149.
3.So, EL, Bainbridge, J, Buchhalter, JR, et al.Report of the American Epilepsy Society and the Epilepsy Foundation joint task force on sudden unexplained death in epilepsy. Epilepsia. 2009;50(4):91722.
4.Ben-Menachem, E, Manon-Espaillat, R, Ristanovic, R, et al.Vagus nerve stimulation for treatment of partial seizures. 1. A controlled study of effect on seizures. First International Vagus Nerve Study Group. Epilepsia. 1994;35(3):61626.
5.Handforth, A, DeGiorgio, CM, Schachter, SC, et al.Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology. 1998;51(1):4855.
6.Morris, GL, Mueller, WM.Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology. 1999;53(8):17315.
7.Rossignol, E, Lortie, A, Thomas, T, et al.Vagus nerve stimulation in pediatric epileptic syndromes. Seizure. 2009;18(1):347.
8.Nicholson, WJ, Tuohy, KA, Tilkemeier, P.Twiddler’s syndrome. N Engl J Med. 2003;348(17):17267.
9.Heck, C, Helmers, SL, DeGiorgio, CM.Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology. 2002;59(6 Suppl 4):S317.
10.DeGiorgio, CM, Schachter, SC, Handforth, A, et al.Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia. 2000;41(9):1195200.
11.Schachter, SC.Vagus nerve stimulation therapy summary. Five years after FDA approval. Neurology. 2002;59(6 Suppl 4):S1520.
12.Ardesch, JJ, Buschman, HP, Wagener-Schimmel, LJ, van der Aa, HE, Hageman, G.Vagus nerve stimulation for medically refractory epilepsy; a long-term follow-up study. Seizure. 2007;16(7):57985.
13.Kuba, R, Brázdil, M, Kalina, M, et al.Vagus nerve stimulation: longitudinal follow-up of patients treated for 5 years. Seizure. 2009;18(4):26974.
14.Boon, P, Vonck, K, Van Walleghem, P, et al.Programmed and magnet-induced vagus nerve stimulation for refractory epilepsy. J Clin Neurophysiol. 2001;18(5):4027.
15.Scherrmann, J, Hoppe, C, Kral, T, et al.Vagus nerve stimulation: clinical experience in a large patient series. J Clin Neurophysiol. 2001;18(5):40814.
16.Vonck, K, Thadani, V, Gilbert, K, et al.Vagus nerve stimulation for refractory epilepsy: a transatlantic experience. J Clin Neurophysiol. 2004;21(4):2839.
17.Amar, AP, Apuzzo, ML, Liu, CY.Vagus nerve stimulation therapy after failed cranial surgery for intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry. Neurosurgery. 2004;55(5):108693.
18.De Herdt, V, Boon, P, Ceulemans, B, et al.Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study. Eur J Paediatr Neurol. 2007;11(5):2619.
19.Muller, K, Fabo, D, Entz, L, et al.Outcome of vagus nerve stimulation for epilepsy in Budapest. Epilepsia. 2010;51(Suppl 3):98101.
20.Ghaemi, K, Elsharkawy, AE, Schulz, R, et al.Vagus nerve stimulation: outcome and predictors of seizure freedom in long-term follow-up. Seizure. 2010;19(5):2648.
21.Alonso-Vanegas, MA, Austria-Velásquez, J, López-Gómez, M, Brust-Mascher, E.Chronic intermittent vagal nerve stimulation in the treatment of refractory epilepsy: experience in Mexico with 35 cases. Cir Cir. 2010;78(1):1523, 24.
22.Wheeler, M, De Herdt, V, Vonck, K, et al. Efficacy of vagus nerve stimulation for refractory epilepsy among patient subgroups: A re-analysis using the Engel classification. Seizure. 2011 Jan 25. [Epub ahead of print]
23.El Tahry, R, De Herdt, V, Raedt, R, et al.Evolution in VNS therapy for refractory epilepsy, experience with Demipulse devices at Ghent University Hospital. Seizure. 2010;19(9):5315.
24.Franzoni, E, Gentile, V, Colonelli, MC, et al.VNS in drug resistant epilepsy: preliminary report on a small group of patients. Ital J Pediatr. 2010;36:30.
25.Guberman, A.Vagus nerve stimulation in the treatment of epilepsy. CMAJ. 2004;171(10):11656.
26.Ho, C, Li, H, Noorani, H, et al.Implantable cardiac defibrillators for primary prevention of sudden cardiac death in high risk patients: a meta-analysis of clinical efficacy, and a review of cost-effectiveness and psychosocial issues [Technology report no 81]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2007.
27.Groupe d’experts en électrophysiologie cardiaque du réseau québécois de cardiologie tertiaire. Évaluation des besoins: tendances et projections 2007-2010. Québec: La Direction des communications du ministère de la Santé et des Services sociaux du Québec; 2007 Nov. 51 p.
28.Renfroe, JB, Wheless, JW.Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy. Neurology. 2002;59(6 Suppl 4):S2630.
29.Boon, P, D’Havé, M, VanWalleghem, P, et al.Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment. Epilepsia. 2002;43(1):96102.
30.Ben-Menachem, E, Hellström, K, Verstappen, D.Analysis of direct hospital costs before and 18 months after treatment with vagus nerve stimulation therapy in 43 patients. Neurology. 2002;59(6 Suppl 4):S447.
31.Ben-Menachem, E.Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol. 2002;1(8):47782. Review.
32.Fisher, R, Salanova, V, Witt, Tet al.and the SANTE study group. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51:899908.
33.Morrell, MJ and the RNS System Pivotal Investigators. Results of a multicenter double blinded randomized controlled pivotal investigation of the RNS system for treatment of intractable partial epilepsy in adults [abstract]. Epilepsia. 2009;50(Suppl. 11):1502.

Vagus Nerve Stimulation for Epilepsy: The Notre-Dame Hospital Experience

  • Mehdi Qiabi (a1), Alain Bouthillier (a2), Lionel Carmant (a1) and Dang Khoa Nguyen (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed